AI ScreeningAI ChatPricing
  1. JP-listed companies
  2. Nissui Pharmaceutical Co., Ltd.
  3. Financials
  4. Stockholders' equity

Nissui Pharmaceutical Co., Ltd.【JP:E00971】

Market cap
P/E ratio
SummaryFinancialsDividendsHistoryWorkforce
Period EndStockholders' equity (Million JPY)YoY (%)
Mar 31, 202232,605+0.38%
Mar 31, 202132,480+0.94%
Mar 31, 202032,176-1.98%
Mar 31, 201932,827-0.45%
Mar 31, 201832,974+1.02%
Mar 31, 201732,642+5.69%
Mar 31, 201630,885-0.34%
Mar 31, 201530,990+6.08%
Mar 31, 201429,213

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)